NetworkNewsAudio Archive - NetworkNewsWire

WednesdayDec 02, 2020 8:30 am

NetworkNewsAudio – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Interview

GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF) is a Canadian junior exploration company active in the Maricunga Gold Belt of Northern Chile. The Maricunga measures 150 km north-south and 30 km. east-west and is host to discoveries in the last 10 years of 100M oz. gold; 450M oz. silver and 1.3 billion lbs. copper. The company has agreements in place to acquire seven projects with extensive surface study. GoldHaven has identified four of its seven properties as “high-priority targets,” three of which the company plans to drill commencing January 2021. These priority targets were designated as such due, first, to the…

TuesdayNov 24, 2020 7:45 am

NetworkNewsAudio – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces FDA Filing of IND for its Brain Cancer Drug Berubicin

Related Press Release CNS Pharmaceuticals (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it has submitted an Investigational New Drug ("IND") application, which has been accepted for review, to the U.S. Food and Drug Administration ("FDA") for Berubicin in the treatment of Glioblastoma Multiforme ("GBM"). The Company plans to evaluate the efficacy of Berubicin in a Phase 2 Trial for adults with GBM who have failed first-line therapy and commence the trial within the first quarter of…

FridayNov 20, 2020 8:30 am

NetworkNewsAudio – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Ideally Positioned as Precious Metal Investment Demand Rises

Related Editorial Investors are flocking to gold, silver and other precious metals in record numbers. One firm, BullionVault, reports that in the past six months demand to invest in gold, silver and platinum has reached almost half a billion dollars. “Net of client selling, investing in physical bullion on our peer-to-peer platform — first opened in 2005 — has now topped $442 million since the pandemic reached Europe and North America in March,” the company said. Mining companies around the world are benefitting from this rising investment tide, as they work to strengthen their positions, increase their holdings and ultimately…

FridayNov 20, 2020 8:30 am

NetworkNewsAudio – Josemaria Resources Inc. (TSX: JOSE) (OTCQB: JOSMF) Sits Pretty as Gold, Copper Prices Reach Record Highs

Related Editorial The surge in the price of gold has been well documented this year. The precious metal closed above $2,000 an ounce earlier this year, leading experts to forecast future prices from $2,300 (Goldman Sachs) to as high as $3,000 (Bank of America) in the coming months. In addition, copper prices have also risen to their highest levels in more than two years, climbing to more than $6,800 a ton. These numbers bode well for companies in the precious metals space, especially companies such as Josemaria Resources Inc. (TSX: JOSE) (OTCQB: JOSMF) (JOSE Profile), which has interests in both…

FridayNov 13, 2020 8:30 am

NetworkNewsAudio – Cybin Inc. (NEO: CYBN) At the Forefront of Psychedelic Therapeutic Protocols, Development

Related Editorial Big pharma and life science companies are making big news these days. The drug-development space is seeing strong investor interest as these companies make breakthrough advancements that address vast unmet medical needs. Strategic M&A moves are adding spice to the gumbo for investors as pioneering research remains focused on providing life-changing treatments for those suffering from a myriad of disorders. One of the largest and trickiest medical disorders of mankind may be on the cusp of more effective treatment. Depression is often kept in the dark and not talked about, but it is estimated that more than 17…

TuesdayOct 27, 2020 8:30 am

NetworkNewsAudio – Predictive Oncology Inc. (NASDAQ: POAI) Interview

Predictive Oncology (NASDAQ: POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer. For more information, visit the company's website at www.Predictive-Oncology.com. NOTE TO INVESTORS: The latest news and updates relating to POAI…

FridayOct 23, 2020 8:30 am

NetworkNewsAudio – 180 Life Sciences Corp. Founders Leverage History of Success Developing, Selling New Drugs to Big Pharma

Related Editorial Pharmaceutical companies invest enormous amounts of time and money on the research and development of new drugs, typically years in the making and costing millions of dollars. Only occasionally is a new drug developed that’s approved and generates more than $1 billion per year in sales, a benchmark in the industry commonly called a “blockbuster.” Blockbusters are scarce, but the proverbial quest for blockbuster drugs continues unabated because of vast unmet medical needs and because blockbuster therapeutics can be worth tens of billions of dollars during their patent-protected lives. Little wonder that pharmaceutical giants often buy up promising…

FridayOct 16, 2020 8:30 am

NetworkNewsAudio – KBL Merger Corp. IV (NASDAQ: KBLM) Identifies 180 Life Sciences Corp. as Perfect Target; Companies Set to Merge

Related Editorial The year 2020 has already seen 127 SPAC IPOs, which have collectively raised over $48.5 billion in proceeds — more than the past ten years combined. A special purpose acquisition company (SPAC) is essentially a blank-check company formed to raise capital through an IPO with the sole intent of buying or merging with another operating company. SPACs have evolved to become an expedited and cost-effective way of doing an M&A deal and have been utilized by multiple Wall Street heavyweights. Going public via a SPAC enables a company to get a deal done in weeks instead of months,…

FridayOct 16, 2020 8:30 am

NetworkNewsAudio – Cybin Corp. Targeting Underserved Mental Illnesses with Drugs Derived from Psychedelics

Related Editorial Compelling evidence of the therapeutic benefits of psychedelic drugs appears in multiple scientific studies. Several clinical trials are underway in the United States and worldwide to investigate the therapeutic effects of psilocybin, the active component in the fungi known colloquially as "magic mushrooms." There is new hope for treating such debilitating disorders as depression, anxiety, post-traumatic stress disorder, anorexia, obsessive-compulsive disorder, and addiction. With more than $6.8 billion on the line by 2027, companies at the vanguard of the psychedelic therapeutic drug market could reap enormous benefits in the coming years. Some of these companies, such as Cybin…

TuesdayOct 06, 2020 8:30 am

NetworkNewsAudio – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Interview

Founded in 2012, The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER) is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in seven unique all-natural flavors with new…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsAudio